BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Koumpa FS, Xylas D, Konopka M, Galea D, Veselkov K, Antoniou A, Mehta A, Mirnezami R. Colorectal Peritoneal Metastases: A Systematic Review of Current and Emerging Trends in Clinical and Translational Research. Gastroenterol Res Pract. 2019;2019:5180895. [PMID: 31065262 DOI: 10.1155/2019/5180895] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 4.3] [Reference Citation Analysis]
Number Citing Articles
1 Lin X, Li Y, Wang S, Zhang Y, Chen X, Wei M, Zhu H, Wu A, Yang Z, Wang X. Diagnostic value of [(68)Ga]Ga-FAPI-04 in patients with colorectal cancer in comparison with [(18)F]F-FDG PET/CT. Front Oncol 2022;12:1087792. [PMID: 36698416 DOI: 10.3389/fonc.2022.1087792] [Reference Citation Analysis]
2 Wong GYM, Bhimani N, Mol B, Diakos C, de Reuver P, Molloy MP, Hugh TJ. Performance of prognostic models incorporating KRAS mutation status to predict survival after resection of colorectal liver metastases. HPB (Oxford) 2022;24:1316-25. [PMID: 35093297 DOI: 10.1016/j.hpb.2022.01.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Hendrikson J, Liu Y, Ng WH, Lee JY, Lim AH, Loh JW, Ng CCY, Ong WS, Tan JW, Tan QX, Ng G, Shannon NB, Lim WK, Lim TKH, Chua C, Wong JSM, Tan GHC, So JBY, Yeoh KG, Teh BT, Chia CS, Soo KC, Kon OL, Tan IB, Chan JY, Teo MCC, Ong CJ; Singapore Peritoneal Oncology Study (SPOS) Group and Singapore Gastric Cancer Consortium (SGCC). Ligand-mediated PAI-1 inhibition in a mouse model of peritoneal carcinomatosis. Cell Rep Med 2022;3:100526. [PMID: 35243423 DOI: 10.1016/j.xcrm.2022.100526] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Braet H, Rahimi-Gorji M, Debbaut C, Ghorbaniasl G, Van Walleghem T, Cornelis S, Cosyns S, Vervaet C, Willaert W, Ceelen W, De Smedt SC, Remaut K. Exploring High Pressure Nebulization of Pluronic F127 Hydrogels for Intraperitoneal Drug Delivery. Eur J Pharm Biopharm 2021:S0939-6411(21)00256-3. [PMID: 34634467 DOI: 10.1016/j.ejpb.2021.10.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
5 Wang PP, Deng CL, Wu B. Magnetic resonance imaging-based artificial intelligence model in rectal cancer. World J Gastroenterol 2021; 27(18): 2122-2130 [PMID: 34025068 DOI: 10.3748/wjg.v27.i18.2122] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 Nindra U, Shahnam A, Mahon KL. Review of systemic chemotherapy in unresectable colorectal peritoneal carcinomatosis. Asia Pac J Clin Oncol 2021. [PMID: 33609014 DOI: 10.1111/ajco.13552] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Dong L, Li K, Peng T. Diagnostic value of diffusion-weighted imaging/magnetic resonance imaging for peritoneal metastasis from malignant tumor: A systematic review and meta-analysis. Medicine (Baltimore) 2021;100:e24251. [PMID: 33592867 DOI: 10.1097/MD.0000000000024251] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
8 Fedyanin MY, Tryakin AA, Ter-ovanesov MD, Tyulyandin SA. DIAGNOSTICS, TREATMENT AND PROGNOSIS IN PATIENTS WITH COLORECTAL CANCER AND PERITONEAL CARCINOMATOSIS (review). Koloproktologiâ 2020;19:131-149. [DOI: 10.33878/2073-7556-2020-19-4-131-149] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
9 Al Hosni M, Rouget C, Cusumano C, Popescu H, Carrere S, Quénet F, Sgarbura O. L’utilisation de la chimiothérapie intrapéritonéale au bloc opératoire : une enquête sur la perception du personnel non-médical. Journal de Chirurgie Viscérale 2020;157:474-480. [DOI: 10.1016/j.jchirv.2020.01.002] [Reference Citation Analysis]
10 Hallam S, Stockton J, Bryer C, Whalley C, Pestinger V, Youssef H, Beggs AD. The transition from primary colorectal cancer to isolated peritoneal malignancy is associated with an increased tumour mutational burden. Sci Rep 2020;10:18900. [PMID: 33144643 DOI: 10.1038/s41598-020-75844-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
11 Lv Q, Cheng L, Lu Y, Zhang X, Wang Y, Deng J, Zhou J, Liu B, Liu J. Thermosensitive Exosome-Liposome Hybrid Nanoparticle-Mediated Chemoimmunotherapy for Improved Treatment of Metastatic Peritoneal Cancer. Adv Sci (Weinh) 2020;7:2000515. [PMID: 32999828 DOI: 10.1002/advs.202000515] [Cited by in Crossref: 37] [Cited by in F6Publishing: 45] [Article Influence: 12.3] [Reference Citation Analysis]
12 Yan Q, Ertao Z, Zhimei Z, Weigang D, Jianjun P, Jianhui C, Chuangqi C. Systemic immune-inflammation index (SII): A More Promising Inflammation-Based Prognostic Marker for Patients with synchronic colorectal peritoneal carcinomatosis. J Cancer 2020;11:5264-72. [PMID: 32742472 DOI: 10.7150/jca.46446] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 5.7] [Reference Citation Analysis]
13 Ravn S, Christiansen CF, Hagemann-Madsen RH, Verwaal VJ, Iversen LH. The Validity of Registered Synchronous Peritoneal Metastases from Colorectal Cancer in the Danish Medical Registries. Clin Epidemiol 2020;12:333-43. [PMID: 32273772 DOI: 10.2147/CLEP.S238193] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
14 Fields AC, Lu PW, Li GZ, Welten V, Jolissaint JS, Vierra BM, Saadat LV, Larson AC, Atkinson RB, Melnitchouk N. Current practices and future steps for hyperthermic intraperitoneal chemotherapy. Curr Probl Surg 2020;57:100727. [PMID: 32151327 DOI: 10.1016/j.cpsurg.2019.100727] [Reference Citation Analysis]
15 Al Hosni M, Rouget C, Cusumano C, Garcia Lozcano E, Popescu H, Carrere S, Quénet F, Sgarbura O. Non-medical caregivers and the use of intraperitoneal chemotherapy in the operating theatre: A survey on the perception of safety. J Visc Surg 2020;157:461-7. [PMID: 32146147 DOI: 10.1016/j.jviscsurg.2020.02.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
16 Tan JW, Tan GHC, Ng WY, Ong CJ, Chia CS, Soo KC, Teo MCC. High-grade complication is associated with poor overall survival after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Int J Clin Oncol 2020;25:984-94. [PMID: 31915944 DOI: 10.1007/s10147-019-01609-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
17 Katdare N, Bhatt A, Glehen O. Biomarkers in the Management of Peritoneal Metastases. Pathology of Peritoneal Metastases 2020. [DOI: 10.1007/978-981-15-3773-8_12] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
18 Wang Q, Deng C, Zhang S, Liu J, Cheng R, Yang N. Benign and Malignant Diagnosis of Hepatocellular Carcinoma on CT Images Based on Fusion Network. 2019 Chinese Automation Congress (CAC) 2019. [DOI: 10.1109/cac48633.2019.8996286] [Reference Citation Analysis]